Literature DB >> 15309879

Gastric and duodenal mucosal protein fractional synthesis and growth factor expression in patients with H. pylori-associated gastritis before and after eradication of the organism.

Trevor A Winter1, Mark Kidd, Philip Kaye, I N Solly Marks.   

Abstract

Our purpose was to study the effect of Helicobacter pylori (HP) on mucosal protein fractional synthesis (MPFS) and growth factor expression. 14C-leucine incorporation, and TGF-alpha, beta-FGF, and EGF-receptor levels were assessed in gastric and duodenal mucosa in 20 patients with HP-associated gastritis and repeated after treatment of the gastritis, with or without eradication of the organism. At entry, MPFS in the fundus, antrum, and duodenum was 43.1, 38.2, and 28.3%/day, respectively. Following HP eradication, fundal and antral rates fell to 28.1 and 21.4%/day (P < 0.05), whereas the duodenum was unchanged. MPFS in the patient subset not eradicated remained similar to entry values (35.9, 31.6, and 25.4%/day). Expression of TGF-alpha, beta-FGF, and EGF receptors was unchanged. Eradication of HP results in reduction of gastric, but not duodenal, MPFS and has no effect on the growth factors measured. Increased MPFS associated with HP gastritis may relate to the potential for neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309879     DOI: 10.1023/b:ddas.0000034550.08623.9b

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Correlation between epithelial cell proliferation and histological grading in gastric mucosa.

Authors:  D A Lynch; N P Mapstone; A M Clarke; P Jackson; P Moayyedi; M F Dixon; P Quirke; A T Axon
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  The Sydney System: a new classification of gastritis. Introduction.

Authors:  J J Misiewicz
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

3.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

4.  Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: Use in studies of human tissue protein synthesis.

Authors:  P W Watt; Y Lindsay; C M Scrimgeour; P A Chien; J N Gibson; D J Taylor; M J Rennie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Increased cell division as a cause of human cancer.

Authors:  S Preston-Martin; M C Pike; R K Ross; P A Jones; B E Henderson
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

6.  mRNA expression of EGF receptor ligands in atrophic gastritis before and after Helicobacter pylori eradication.

Authors:  Uwe Schiemann; Jan Konturek; Ronald Assert; Kazimierz Rembiasz; Wolfram Domschke; Stanisław Konturek; Aadreas Pfeiffer
Journal:  Med Sci Monit       Date:  2002-02

7.  Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans.

Authors:  T Zhang; S J O'Keefe; T Winter; I N Marks; J Ogden
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

Review 8.  The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways.

Authors:  A S Tarnawski; M K Jones
Journal:  J Clin Gastroenterol       Date:  1998       Impact factor: 3.062

9.  Measurement of gastric and duodenal mucosal protein turnover in humans.

Authors:  S J O'Keefe
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

10.  Energy and protein metabolism in malnutrition due to nonneoplastic gastrointestinal diseases.

Authors:  F Carbonnel; B Messing; D Darmaun; A Rimbert; M Rongier; O Rigal; J Koziet; F Thuillier; J F Desjeux
Journal:  Metabolism       Date:  1995-09       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.